New search | Conferencedetail
Print view
 
 

Treg Directed Therapy for Autoimmune Disorders Summit 2018

evvnt Platform / evvnt
-
22.05.2018 - 24.05.2018  Westin Boston Waterfront, 425 Summer Street, 02210 Boston, USA
8:00 am to 4:00 pm
 
Conference themes
This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells.
URLs: Brochure:https://go.evvnt.com/197029-1?pid=4832
Inquiries: https://go.evvnt.com/197029-2?pid=4832
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Chris Haqq, Kevin Gorski, Nadia Tchao, David Wraith, Andrew Scharenberg, Simrit Parmar, Robert Plenge, Stephen Miller, Todd Brusko, Jeremie Mariau, Laurence Turka, Jason Fontenot, Leonard Dragone
 

Enquiries and Registration:

https://go.evvnt.com/197029-0?pid=4832
Ms. Georgina FitzGerald
 
Categories
Internal Medicine
Languages
English
Congress fees
USD 499,00
(Conference Only (Earlybird ends Feb 23): USD 1999, Conference Only (Earlybird ends Mar 23): USD 2199,Conference Only: USD 2799,Workshop Only: USD 499)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
Tel: +44 0207 3230 450
hello@evvnt.com
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

newTreeÄrzte der WeltÖsterreichisches Rotes KreuzFFG - 7. EU-RahmenprogrammCharité International AcademyHilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Public Health Association (EUPHA)

Facebook

Give us your professional opinion

Start survey

Start survey